These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 26369546

  • 1. CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.
    Chuang WY, Chang H, Shih LY, Wang PN, Chang YS, Lin TL, Hung YS, Yeh CJ, Ueng SH, Tang TC, Kuo MC, Dunn P, Wu JH, Kao HW, Ou CW, Wan YL, Hsueh C.
    Virchows Arch; 2015 Nov; 467(5):571-82. PubMed ID: 26369546
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019 Nov; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 3. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.
    Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS.
    Blood; 2007 Aug 01; 110(3):972-8. PubMed ID: 17400912
    [Abstract] [Full Text] [Related]

  • 8. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
    Wen JJ, Liu ZB, Xu J, Xu CG.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec 01; 33(12):1004-9. PubMed ID: 23363791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
    Chang ST, Lu YH, Lu CL, Weng SF, Lin SH, Kuo SY, Chuang YT, Takeuchi K, Ohshima K, Chuang SS.
    J Clin Pathol; 2014 Apr 01; 67(4):326-32. PubMed ID: 24218026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
    Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM.
    Am J Hematol; 2016 May 01; 91(5):529-37. PubMed ID: 27093913
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
    Ishikawa E, Kato S, Shimada K, Tanaka T, Suzuki Y, Satou A, Kohno K, Sakakibara A, Yamamura T, Nakamura M, Miyahara R, Goto H, Nakamura S, Hirooka Y.
    Cancer Med; 2018 Dec 01; 7(12):6051-6063. PubMed ID: 30449068
    [Abstract] [Full Text] [Related]

  • 16. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L, Min M, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr 01; 40(4):220-6. PubMed ID: 21615994
    [Abstract] [Full Text] [Related]

  • 17. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].
    Han YS, Xue YQ, Yang HY, Zhang J, Pan JL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr 01; 30(2):143-7. PubMed ID: 23568722
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
    Ziarkiewicz M, Wołosz D, Dzieciątkowski T, Wilczek E, Dwilewicz-Trojaczek J, Jędrzejczak WW, Gierej B, Ziarkiewicz-Wróblewska B.
    Arch Immunol Ther Exp (Warsz); 2016 Apr 01; 64(2):159-69. PubMed ID: 26084760
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
    Gao X, Li J, Wang Y, Liu S, Yue B.
    PLoS One; 2018 Apr 01; 13(6):e0199398. PubMed ID: 29920566
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.
    Liang JH, Lu TX, Tian T, Wang L, Fan L, Xu J, Zhang R, Gong QX, Zhang ZH, Li JY, Xu W.
    Clin Microbiol Infect; 2015 Jun 01; 21(6):596-602. PubMed ID: 25743579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.